What is PTC Therapeutics's current debt?

PTC Therapeutics (PTCT) reported current debt of $286.94M in Q1 2026.

How has PTC Therapeutics's current debt changed year-over-year?

PTC Therapeutics's current debt increased by 5585.3% year-over-year, from $5.05M to $286.94M.

What is the long-term trend for PTC Therapeutics's current debt?

Over 5 years (2020 to 2025), PTC Therapeutics's current debt has grown at a 195.3% compound annual growth rate (CAGR), from $1.28M to $286.63M.

What does current debt mean?

The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

PTC Therapeutics PTCT Current Debt

Current Debt at other companies

Tenet HealthcareTHC

$81M-8.0%

CytokineticsCYTK

$44.81M+246%

InsmedINSM

$3.45M+12.8%

BridgeBio PharmaBBIO

——

ModernaMRNA

——

Other financials

Income statement

See full

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Debt / equity372.3×—

Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's current debt?: PTC Therapeutics (PTCT) reported current debt of $286.94M in Q1 2026.
How has PTC Therapeutics's current debt changed year-over-year?: PTC Therapeutics's current debt increased by 5585.3% year-over-year, from $5.05M to $286.94M.
What is the long-term trend for PTC Therapeutics's current debt?: Over 5 years (2020 to 2025), PTC Therapeutics's current debt has grown at a 195.3% compound annual growth rate (CAGR), from $1.28M to $286.63M.
What does current debt mean?: The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.